Skip to content

Efficacy Evaluation of Collagen Drink Products

Efficacy Evaluation of Collagen Drink Products

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06194487
Enrollment
91
Registered
2024-01-08
Start date
2023-10-01
Completion date
2024-01-26
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Condition

Brief summary

To assess MAXI Collagen drink on skin condition improvement

Interventions

DIETARY_SUPPLEMENTPlacebo drink

consume 1 bottle (50mL) per day

DIETARY_SUPPLEMENTMAXI Collagen drink

consume 1 bottle (50mL) per day

DIETARY_SUPPLEMENTNormal fish collagen drink

consume 1 bottle (50mL) per day

Sponsors

TCI Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
35 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults aged 35-65 years old

Exclusion criteria

* Subject with skin surface damage larger than $50 coin area. * Subject who had skin allergies caused by diet or undrwent cosmetic or medical treatment within 6 months. * Subject who is a vegetarian and allergic to seafood, alcohol or listed ingredients in the product. * Students who are currently taking courses taught by the principal investigator of this trial.

Design outcomes

Primary

MeasureTime frameDescription
The change of skin textureDay 0, Day 7, Day 28VISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units
The change of skin elasticityDay 0, Day 7, Day 28Cutometer® Dual MPA 580 was utilized to measure skin elasticity. Units: arbitrary units
The change of skin moistureDay 0, Day 7, Day 28Corneometer® CM825 was utilized to measure skin moisture. Units: arbitrary Corneometer® units 0-120
The change of skin collagen densityDay 0, Day 7, Day 28DermaLab® Series SkinLab Combo was utilized to measure skin collagen density. Units: arbitrary units

Secondary

MeasureTime frameDescription
The change of self-assessment skin conditionDay 0, Day 7, Day 28A self-assessment questionnaire was collected to evaluate skin condition
The change of skin colourDay 0, Day 7, Day 28PANTONE® CAPSURE™ RM200-PT01 was utilized to measure skin colour. Units: arbitrary units
The change of transepidermal water loss (TEWL)Day 0, Day 7, Day 28Tewameter® TM 300 was utilized to measure TEWL. Units: g/hm²
The change of skin wrinklesDay 0, Day 7, Day 28VISIA Complexion Analysis System was utilized to measure skin wrinkles. Units: arbitrary units
The change of skin poresDay 0, Day 7, Day 28VISIA Complexion Analysis System was utilized to measure skin pores. Units: arbitrary units

Other

MeasureTime frameDescription
The change of liver function biomarkers (GOT, GPT) of bloodDay 0, Day 28Fasting venous blood was sampled to measure liver function biomarkers
The change of fasting blood glucoseDay 0, Day 28Fasting venous blood was sampled to measure blood glucose
The change of renal function biomarkers (creatinine, BUN) of bloodDay 0, Day 28Fasting venous blood was sampled to measure renal function biomarkers

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026